Pharmaceutical Research

Pharmaceutical Strategies Utilizing Recombinant Human Serum Albumin
pp. 569-577(9)
Authors: Tuan Giam Chuang V.; Kragh-Hansen U.; Otagiri M.

Polymers and Gels as Molecular Recognition Agents
pp. 578-587(10)
Authors: Peppas N.A.; Huang Y.

In Vitro Characterization of Hepatic Flavopiridol Metabolism Using Human Liver Microsomes and Recombinant UGT Enzymes
pp. 588-594(7)
Authors: Ramírez J.; Iyer L.; Journault K.; Bélanger P.; Innocenti F.; Ratain M.J.; Guillemette C.

Transfer of Lipophilic Markers from PLGA and Polystyrene Nanoparticles to Caco-2 Monolayers Mimics Particle Uptake
pp. 595-601(7)
Authors: Pietzonka P.; Rothen-Rutishauser B.; Langguth P.; Wunderli-Allenspach H.; Walter E.; Merkle H.P.

The Role of Glutathione in the Permeation Enhancing Effect of Thiolated Polymers
pp. 602-608(7)
Authors: Clausen A.E.; Kast C.E.; Bernkop-Schnürch A.

Structure-Activity Relationship of Reversibly Lipidized Peptides: Studies of Fatty Acid-Desmopressin Conjugates
pp. 609-614(6)
Authors: Wang J.; Wu D.; Shen W-C.

In Vivo Kinetic Analysis of Covalent Binding Between N-Acetyl-L-Cysteine and Plasma Protein Through the Formation of Mixed Disulfide in Rats
pp. 615-620(6)
Authors: Harada D.; Naito S.; Hiraoka I.; Otagiri M.

Insulin Aspart (Asp^B28 Human Insulin) Derivatives Formed in Pharmaceutical Solutions
pp. 621-628(8)
Authors: Jars M.U.; Hvass A.; Waaben D.

Lysozyme Stability in Primary Emulsion for PLGA Microsphere Preparation: Effect of Recovery Methods and Stabilizing Excipients
pp. 629-633(5)
Authors: Kang F.; Jiang G.; Hinderliter A.; DeLuca P.P.; Singh J.

Analysis Methods of Polysorbate 20: A New Method to Assess the Stability of Polysorbate 20 and Established Methods That May Overlook Degraded Polysorbate 20
pp. 634-639(6)
Authors: Khossravi M.; Kao Y-H.; Mrsny R.J.; Sweeney T.D.

Influence of Polymorphism on the Surface Energetics of Salmeterol Xinafoate Crystallized from Supercritical Fluids
pp. 640-648(9)
Authors: Tong H.H.Y.; Shekunov B.Y.; York P.; Chow A.H.L.

Influence of Alkali Metal Counterions on the Glass Transition Temperature of Amorphous Indomethacin Salts
pp. 649-654(6)
Authors: Tong P.; Taylor L.S.; Zografi G.

High Throughput Screening of Transdermal Formulations
pp. 655-660(6)
Authors: Karande P.; Mitragotri S.

Transdermal Delivery of Highly Lipophilic Drugs: In Vitro Fluxes of Antiestrogens, Permeation Enhancers, and Solvents from Liquid Formulations
pp. 661-668(8)
Authors: Funke A.P.; Schiller R.; Motzkus H.W.; Günther C.; Müller R.H.; Lipp R.

Utility of MTT Assay in Three-Dimensional Cultured Human Skin Model as an Alternative for Draize Skin Irritation Test: Approach Using Diffusion Law of Irritant in Skin and Toxicokinetics-Toxicodynamics Correlation
pp. 669-675(7)
Authors: Watanabe T.; Hasegawa T.; Takahashi H.; Ishibashi T.; Itagaki H.; Sugibayashi K.

Massive and Selective Delivery of Lipid-Coated Cationic Lipoplexes of Oligonucleotides Targeted in Vivo to Hepatic Endothelial Cells
pp. 676-680(5)
Authors: Bartsch M.; Weeke-Klimp A.H.; Meijer D.K.F.; Scherphof G.L.; Kamps J.A.A.M.

Self-Assembled Hydrogel Nanoparticles Responsive to Tumor Extracellular pH from Pullulan Derivative/Sulfonamide Conjugate: Characterization, Aggregation, and Adriamycin Release in Vitro
pp. 681-688(8)
Authors: Na K.; Bae Y.H.

Improved Lung Delivery from a Passive Dry Powder Inhaler Using an Engineered PulmoSphere® Powder
pp. 689-695(7)
Authors: Duddu S.P.; Sisk S.A.; Walter Y.H.; Tarara T.E.; Trimble K.R.; Clark A.R.; Eldon M.A.; Elton R.C.; Pickford M.; Hirst P.H.; Newman S.P.; Weers J.G.

Drug Disposition Viewed in Terms of the Fractal Volume of Distribution
pp. 697-704(8)
Authors: Karalis V.; Macheras P.

Transdermal Iontophoresis of Tacrine in Vivo
pp. 705-708(4)
Authors: Kankkunen T.; Sulkava R.; Vuorio M.; Kontturi K.; Hirvonen J.

Blunted Induction of Hepatic CYP4A in TNF (p55^‐/‐/p75^‐/‐) Double Receptor Knockout Mice Following Clofibrate Treatment
pp. 709-713(5)
Authors: Van Ess P.J.; Poloyac S.; Mattson M.P.; Blouin R.A.

AAPS Electronic Scientist
pp. 714-715(2)